In vitiligo, hypopigmented or depigmented areas of skin occur as a result of an autoimmune disorder. The results of a large international survey confirm that vitiligo sufferers sometimes experience considerable distress. The therapeutic options have expanded in recent years. This applies in particular to the most common subtype, namely non-segmental vitiligo.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- MASH
Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges?
- Obesity Treatment
Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward
- Older patients with atopic dermatitis
Why the Use of Biologics Is Recommended
- Disorders of the Gut-Brain Interaction
Peppermint-Caraway Oil Supplement Proves Effective in Phase IV Trial
- Gepante for Migraines
Relief from pain, symptoms, and improved functional ability—both acute and preventive
- Why the Finerenon Boom Is Giving Hyperkalemia Treatment New Relevance
Potassium binders as enablers of RAASi optimization
- Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy
Remodeling can be counteracted through a proactive treatment strategy
- From symptom to diagnosis